News
ELAT
21.32
0.00%
0.00
Bayer must face US company's flea and tick drug antitrust lawsuit
Bayer must face US company's flea and tick drug antitrust lawsuit. Pet products company Tevra says Bayer schemed to block its generic, lower-cost pet medication. Bayer has denied any wrongdoing. The plaintiffs could pursue damages after Bayer exits the animal health market.
Reuters · 3d ago
BRIEF-FDA Approved Pradalex Solution For Certain Respiratory Diseases In Cattle And Swine
FDA Approved Pradalex Solution For Certain Respiratory Diseases In Cattle And Swine. FDA approved the drug for treatment of certain respiratory diseases in cattle and swine. The drug is not intended for use in sheep or pigs, the company says.
Reuters · 04/09 17:06
FDA: PRADALEX IS SPONSORED BY ELANCO US INC.
Reuters · 04/09 17:01
FDA: PRADALEX MAY ONLY BE PRESCRIBED FOR WEANED SWINE INTENDED FOR SLAUGHTER; IT IS NOT FOR USE IN SWINE INTENDED FOR BREEDING OR NURSING PIGLETS
Reuters · 04/09 17:01
UPDATE 1-Elanco appoints two directors after settling with activist Ancora
Elanco Animal Health appoints two directors after reaching agreement with activist investor Ancora Holdings. The company makes medicines and vaccinations for pets and livestock. The investment firm had said in February it wanted four board seats at Elanco and to replace CEO Jeffrey Simmons. Elanco stopped short of appointing a CEO.
Reuters · 04/01 11:00
Elanco appoints two directors to its board after agreement with Ancora
Elanco appoints two directors to its board after agreement with Ancora Holdings. Elanco Animal Health appointed two independent directors to board. The two directors were appointed by investment firm AnCora Holdings, Elanco says. The animal health company says it has agreed to appoint the independent directors.
Reuters · 04/01 10:39
ELANCO ANIMAL HEALTH INC - NEW DIRECTORS JOIN BOARD'S RENAMED FINANCE, STRATEGY AND OVERSIGHT COMMITTEE
Reuters · 04/01 10:30
Activist investor Ancora secures two Elanco board seats, Bloomberg News reports
Activist investor Ancora Holdings has reached an agreement with Elanco Animal Health to add two of its director candidates to the company's board. Elanco CEO Jeff Simmons will retain his position, Bloomberg News reports. In February, An cora had said it was pushing for four board seats at Elanco.
Reuters · 04/01 03:37
ACTIVIST INVESTOR ANCORA WINS TWO BOARD SEATS AT ELANCO - BLOOMBERG NEWS
Reuters · 04/01 02:54
EXCLUSIVE-Ancora seeks four board seats at Elanco amid push for changes, sources say
Ancora Holdings is pushing for four board seats at Elanco Animal Health amid push for changes, sources say. Ancora wants to oust CEO Jeffrey Simmons over what it calls poor performance. The firm blames Simmons for a 55% share price drop since Elanco's purchase of Bayer Animal Health.
Reuters · 02/29 12:00
BUZZ-U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
Wall Street's main indexes were mixed in choppy trade on Monday. Dow Jones Industrial Average .DJI was down 0.23% at 39,040.07. The top three S&P 500 percentage gainers were Palo Alto Networks, Dominos Pizza and Micron Technology.
Reuters · 02/26 19:03
BUZZ-U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
Dow Jones Industrial Average was up 0.15% on Monday. Micron, Krystal Biotech, Pilgrim's Pride and Dominos Pizza were among the top gainers. Wall Street edged higher on Monday after a scorching AI-led rally. Investor focus returned to key inflation and economic data expected this week.
Reuters · 02/26 16:00
Elanco Animal Health Inc reports results for the quarter ended in December - Earnings Summary
Elanco Animal Health Inc reports quarterly adjusted earnings of 8 cents per share for the quarter ended in December. Revenue rose 4.8% to $1.04 billion from a year ago. The company reported a quarterly loss of $141 million. The average analyst rating on the shares is "buy"
Reuters · 02/26 14:30
BUZZ-U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet
Dow e-minis set for a subdued open on Monday. Investors focus returned to potential rate cuts from the Federal Reserve. Top three NYSE percentage gainers premarket were Agiliti, Voyager, Freshpet. Domino's Pizza up 6.8% after beating quarterly sales.
Reuters · 02/26 14:13
BUZZ-Elanco falls after Q4 profit miss
Elanco posts Q4 adj. Profit of 8 cents per share, missing analysts' estimate of 11 cents. Shares of animal health company Elanco fall 2.5% to $15.96 premarket. Company forecasts 2024 revenue in the range of $4.54 million.
Reuters · 02/26 12:46
BRIEF-Elanco Animal Health Q4 Revenue USD 1,035 Million Vs. IBES Estimate USD 1,002 Million
Elanco Animal Health reports Q4 revenue of $1.035 million. Q4 adjusted EBITDA was $165 million. The company says it expects to report a full year of $4.5 million in revenue. The animal health company expects to post a FY profit of $0.95 per share.
Reuters · 02/26 11:27
BUZZ-U.S. STOCKS ON THE MOVE-MorphoSys AG, DocuSign, Invitae
Wall Street's main indexes fell on Monday. Dow Jones Industrial Average was down 0.74% at 38,366.48. Top three S&P 500 percentage gainers: Estee Lauder, MorphoSys AG and Caterpillar. The Nasdaq Composite was down 1.01%.
Reuters · 02/05 18:49
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, New York Community Bancorp, GlobalFoundries
Wall Street opened lower on Monday. The Dow Jones Industrial Average was down 0.92% at 38,299.49. Tesla, New York Community Bancorp and Caterpillar were among the biggest losers. Estee Lauder was the biggest gainer on the S&P 500 and the Nasdaq.
Reuters · 02/05 16:02
BUZZ-U.S. STOCKS ON THE MOVE-Estee Lauder, Nvidia, Everbridge
Wall Street poised for a slightly lower open on Monday. Dow e-minis were down 0.28% in early trading. Treasury yields rose after Fed Chair Jerome Powell pushed back against market speculations of imminent rate cuts. Estee Lauder, Nvidia, Everbridge and Caterpillar were among the top stocks on the NYSE.
Reuters · 02/05 14:17
BUZZ-Elanco rises on sale of aqua business to Merck for $1.3 bln
Elanco Animal Health shares rise 6.25% to $15.65 premarket. Merck agrees to buy Elanco's aqua business for $1.3 bln in cash. Deal will help Merck strengthen its portfolio of aquatic healthcare products. Elanco shares have risen 1% in the last 12 months.
Reuters · 02/05 12:08
More
Webull provides a variety of real-time ELAT stock news. You can receive the latest news about Elanco Animal Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About ELAT
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its farm animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others